Dr. Yen-Yin Lin has started up JelloX Biotech Inc. and served as CEO to lead not only innovative 3D tissue clearance and digital pathology research development but also versatile 3D + AI digital pathology platform product development since 2019. He has passion in deep science-based technology and medical application-driven engineering as evidenced of abundant scientific publication and invention patents. His broad network from academic and global biotech industry has created massive business opportunities of integrated digital pathology solution coupling with multidimensional tumor atlas along with domestic hospital systems and global partners including Roche and Intel. Under Yen-Yin’s leadership JelloX Biotech Inc. has accumulated reputable track records including publication, patent, FDA listed tissue clearing solution, Academic Entrepreneur Pioneer Award, Future Technology Award, Business Startup Award, Boehringer Ingelheim Grass Roots Award, Best Bio Startup CEO Award, and recognition as Intel Market Ready Solution partner. Dr. Yen-Yin Lin sees unmet medical need of matching right patients to right drugs with unique MetaLite software developed by JelloX Biotech, which in turn bridges the company to IT industry for further collaboration and co-promotion with more social impact.